These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9800146)

  • 1. Retention in treatment of heroin users in Italy: the role of treatment type and of methadone maintenance dosage.
    D'Ippoliti D; Davoli M; Perucci CA; Pasqualini F; Bargagli AM
    Drug Alcohol Depend; 1998 Oct; 52(2):167-71. PubMed ID: 9800146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retention in a low-threshold methadone maintenance program.
    Torrens M; Castillo C; Pérez-Solá V
    Drug Alcohol Depend; 1996 May; 41(1):55-9. PubMed ID: 8793310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT; Tait RJ; Hulse GK
    Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naltrexone in methadone maintenance patients electing to become "drug free".
    Haas N; Ling W; Holmes E; Blakis M; Litaker M
    NIDA Res Monogr; 1976 Sep; (9):70-3. PubMed ID: 794723
    [No Abstract]   [Full Text] [Related]  

  • 5. Experiences with an outpatient relapse program (community reinforcement approach) combined with naltrexone in the treatment of opioid-dependence: effect on addictive behaviors and the predictive value of psychiatric comorbidity.
    Roozen HG; Kerkhof AJ; van den Brink W
    Eur Addict Res; 2003 Apr; 9(2):53-8. PubMed ID: 12644730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retention in methadone maintenance and heroin addicts' risk of death.
    Caplehorn JR; Dalton MS; Cluff MC; Petrenas AM
    Addiction; 1994 Feb; 89(2):203-9. PubMed ID: 8173486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Client variables associated with selection and outcome in a methadone tapering program.
    Capone CT; Haggerty EL; Acer K; Melchionda R; Holley E; Adams H; Logan F
    Int J Addict; 1994 Feb; 29(3):387-94. PubMed ID: 8188434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of retention in naltrexone maintenance for opioid dependence: analysis of a stage I trial.
    Sullivan MA; Rothenberg JL; Vosburg SK; Church SH; Feldman SJ; Epstein EM; Kleber HD; Nunes EV
    Am J Addict; 2006; 15(2):150-9. PubMed ID: 16595353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methadone and naltrexone in the treatment of heroin dependence.
    Greenstein RA; Resnick RB; Resnick E
    Psychiatr Clin North Am; 1984 Dec; 7(4):671-9. PubMed ID: 6522309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Topping up' methadone: an analysis of patterns of heroin use among a treatment sample of Scottish drug users.
    Bloor M; McIntosh J; McKeganey N; Robertson M
    Public Health; 2008 Oct; 122(10):1013-9. PubMed ID: 18490036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of abstinence-oriented and indefinite methadone maintenance treatment.
    Caplehorn JR
    Int J Addict; 1994 Sep; 29(11):1361-75. PubMed ID: 7829275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-efficacy and HIV risk behaviors among heroin users in Taiwan.
    Ko NY; Wang PW; Wu HC; Yen CN; Hsu ST; Yeh YC; Chung KS; Yen CF
    J Stud Alcohol Drugs; 2012 May; 73(3):469-76. PubMed ID: 22456252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors for dropping-out from methadone maintenance therapy programs among heroin users in southern Taiwan.
    Lin HC; Chen KY; Wang PW; Yen CF; Wu HC; Yen CN; Yeh YC; Chung KS; Chang HC
    Subst Use Misuse; 2013 Jan; 48(1-2):181-91. PubMed ID: 23368704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retention and its predictors among methadone maintenance treatment clients in China: a six-year cohort study.
    Cao X; Wu Z; Rou K; Li L; Lin C; Wang C; Luo W; Pang L; Yin W; Li J;
    Drug Alcohol Depend; 2014 Dec; 145():87-93. PubMed ID: 25448082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance treatment with depot opioid antagonists in subcutaneous implants: an alternative in the treatment of opioid dependence.
    Carreño JE; Alvarez CE; Narciso GI; Bascarán MT; Díaz M; Bobes J
    Addict Biol; 2003 Dec; 8(4):429-38. PubMed ID: 14690879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prohibition of take-home dosages: negative consequences on methadone maintenance treatment.
    Pani PP; Pirastu R; Ricci A; Gessa GL
    Drug Alcohol Depend; 1996 May; 41(1):81-4. PubMed ID: 8793314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methadone dose levels and client characteristics in heroin addicts.
    Metzger DS; Platt JJ
    Int J Addict; 1987 Feb; 22(2):187-94. PubMed ID: 3570573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating the influence of treatment philosophy on outcome of methadone maintenance.
    Bell J; Chan J; Kuk A
    Addiction; 1995 Jun; 90(6):823-30. PubMed ID: 7633300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Factors influencing the rate on retention to methadone maintenance treatment program among heroin addicts in Guizhou, China].
    Liang T; Liu EW; Zhong H; Wang B; Shen LM; Wu ZL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):131-5. PubMed ID: 19565871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detoxification from heroin using self vs physician regulation of methadone dose.
    Fulwiler RL; Hargreaves WA; Bortman RA
    Int J Addict; 1979 Feb; 14(2):289-98. PubMed ID: 447434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.